Recent development of balloon-occluded retrograde transvenous obliteration

Masao Kobayakawa, Shin Ohnishi, Hidekazu Suzuki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Gastric varices (GVs) are a major complication of portal hypertension in patients with liver cirrhosis. The mortality rate associated with the bleeding from GVs is not low. Balloon-occluded retrograde transvenous obliteration (BRTO) was first introduced by Kanagawa et al. as a treatment for isolated GVs in 1994. It has been performed most frequently in Asia, especially in Japan. Ethanolamine oleate was the original sclerosant used in the therapy. Since the late 2000s, BRTO using sodium tetradecyl sulfate foam or polidocanol foam as a sclerosant has been performed in many countries other than Japan. Then, early in the 2010s, modified BRTO techniques including vascular plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration were developed as an alternative treatment for GVs. This article provides a historical overview of BRTO using various sclerosants and modified BRTO techniques, such as plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration.

Original languageEnglish
JournalJournal of Gastroenterology and Hepatology (Australia)
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Esophageal and Gastric Varices
Sclerosing Solutions
Japan
Sodium Tetradecyl Sulfate
Portal Hypertension
Liver Cirrhosis
Blood Vessels
Therapeutics
Hemorrhage
Mortality

Keywords

  • balloon-occluded retrograde transvenous obliteration
  • coil
  • ethanolamine oleate
  • polidocanol
  • sodium tetradecyl sulfate
  • vascular plug

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Recent development of balloon-occluded retrograde transvenous obliteration. / Kobayakawa, Masao; Ohnishi, Shin; Suzuki, Hidekazu.

In: Journal of Gastroenterology and Hepatology (Australia), 01.01.2018.

Research output: Contribution to journalArticle

@article{2882e7f7561d4b06a0dc09b9c6e594fc,
title = "Recent development of balloon-occluded retrograde transvenous obliteration",
abstract = "Gastric varices (GVs) are a major complication of portal hypertension in patients with liver cirrhosis. The mortality rate associated with the bleeding from GVs is not low. Balloon-occluded retrograde transvenous obliteration (BRTO) was first introduced by Kanagawa et al. as a treatment for isolated GVs in 1994. It has been performed most frequently in Asia, especially in Japan. Ethanolamine oleate was the original sclerosant used in the therapy. Since the late 2000s, BRTO using sodium tetradecyl sulfate foam or polidocanol foam as a sclerosant has been performed in many countries other than Japan. Then, early in the 2010s, modified BRTO techniques including vascular plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration were developed as an alternative treatment for GVs. This article provides a historical overview of BRTO using various sclerosants and modified BRTO techniques, such as plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration.",
keywords = "balloon-occluded retrograde transvenous obliteration, coil, ethanolamine oleate, polidocanol, sodium tetradecyl sulfate, vascular plug",
author = "Masao Kobayakawa and Shin Ohnishi and Hidekazu Suzuki",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/jgh.14463",
language = "English",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Recent development of balloon-occluded retrograde transvenous obliteration

AU - Kobayakawa, Masao

AU - Ohnishi, Shin

AU - Suzuki, Hidekazu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Gastric varices (GVs) are a major complication of portal hypertension in patients with liver cirrhosis. The mortality rate associated with the bleeding from GVs is not low. Balloon-occluded retrograde transvenous obliteration (BRTO) was first introduced by Kanagawa et al. as a treatment for isolated GVs in 1994. It has been performed most frequently in Asia, especially in Japan. Ethanolamine oleate was the original sclerosant used in the therapy. Since the late 2000s, BRTO using sodium tetradecyl sulfate foam or polidocanol foam as a sclerosant has been performed in many countries other than Japan. Then, early in the 2010s, modified BRTO techniques including vascular plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration were developed as an alternative treatment for GVs. This article provides a historical overview of BRTO using various sclerosants and modified BRTO techniques, such as plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration.

AB - Gastric varices (GVs) are a major complication of portal hypertension in patients with liver cirrhosis. The mortality rate associated with the bleeding from GVs is not low. Balloon-occluded retrograde transvenous obliteration (BRTO) was first introduced by Kanagawa et al. as a treatment for isolated GVs in 1994. It has been performed most frequently in Asia, especially in Japan. Ethanolamine oleate was the original sclerosant used in the therapy. Since the late 2000s, BRTO using sodium tetradecyl sulfate foam or polidocanol foam as a sclerosant has been performed in many countries other than Japan. Then, early in the 2010s, modified BRTO techniques including vascular plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration were developed as an alternative treatment for GVs. This article provides a historical overview of BRTO using various sclerosants and modified BRTO techniques, such as plug-assisted retrograde transvenous obliteration and coil-assisted retrograde transvenous obliteration.

KW - balloon-occluded retrograde transvenous obliteration

KW - coil

KW - ethanolamine oleate

KW - polidocanol

KW - sodium tetradecyl sulfate

KW - vascular plug

UR - http://www.scopus.com/inward/record.url?scp=85053471657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053471657&partnerID=8YFLogxK

U2 - 10.1111/jgh.14463

DO - 10.1111/jgh.14463

M3 - Article

C2 - 30170340

AN - SCOPUS:85053471657

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

ER -